DXCM vs. VEEV: DexCom vs. Veeva Systems Stock Comparison

Company Profile

DexCom (DXCM) and Veeva Systems (VEEV) both fall under the Health Care Equipment & Services industry group, but DXCM is classified in Health Care Equipment & Supplies while VEEV is classified in Health Care Technology.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both DexCom (DXCM) at 37.67% and Veeva Systems (VEEV) at 14.43% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.

For every dollar of sales, both DexCom (DXCM) at 19.42% and Veeva Systems (VEEV) at 29.35% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

Both DexCom (DXCM) at 24.34% and Veeva Systems (VEEV) at 29.64% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

Profitability Metrics

Growth

Both DexCom (DXCM) at 15.60% and Veeva Systems (VEEV) at 16.34% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

DexCom (DXCM) at 47.18% sits in the top EPS growth quartile, while Veeva Systems (VEEV) at 25.93% is closer to the peer norm — faster per-share earnings growth for DXCM.

Growth Metrics

Financial Strength

DexCom (DXCM) at 1.74 keeps current ratio within its industry’s typical mid-range, while Veeva Systems (VEEV) at 5.46 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.

Veeva Systems (VEEV) at 0.02 keeps leverage in the lower industry quartile, while DexCom (DXCM) at 0.55 runs a more typical debt-to-equity mix.

Financial Strength Metrics

Dividends

Neither DexCom (DXCM) nor Veeva Systems (VEEV) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Neither DexCom (DXCM) nor Veeva Systems (VEEV) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Dividend Metrics

Valuation

DexCom (DXCM) at 31.26 is near its industry’s usual P/E ratio, while Veeva Systems (VEEV) at 49.79 sits in the richer quartile — VEEV needs stronger growth or earnings quality to justify the premium.

Both look expensive on sales: DexCom (DXCM) at 5.80 sits in the upper P/S ratio quartile, and Veeva Systems (VEEV) at 14.22 prices even higher, above its industry range.

Both DexCom (DXCM) at 11.68 and Veeva Systems (VEEV) at 6.61 carry a premium to book value versus peers, sitting in the upper P/B ratio quartile of their industries.

Valuation Metrics